Biotechne press release
WebApr 12, 2024 · MINNEAPOLIS, April 12, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 3, 2024, at 8:00 a.m. CDT to review third quarter 2024 financial results. Access to the discussion may be obtained as follows: Time: 8:00 a.m. …
Biotechne press release
Did you know?
Web1 day ago · MINNEAPOLIS, April 13, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will present its portfolio of products and solutions to advance cancer research and enable cell and gene therapy development and manufacturing at the upcoming annual meeting of the American Association for Cancer Research … WebAbout Us. Bio-Techne empowers researchers in Life Science and Clinical Diagnostics by providing high-quality reagents, instruments, custom manufacturing, and testing services. Our family of brands creates a unique portfolio of products and services. Science is our passion; it drives us to collaborate, develop, and manufacture award-winning ...
WebApr 13, 2024 · MINNEAPOLIS, April 13, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will present its portfolio of products and solutions to advance cancer research and enable cell and gene therapy development and manufacturing at the upcoming annual meeting of the American Association for Cancer Research … WebOct 13, 2024 · PRESS RELEASE PR Newswire . Oct. 13, 2024, 07:00 AM. MINNEAPOLIS, Oct. 13, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call ...
Web1 day ago · Press Release Distributed by The Express Wire . To view the original version on The Express Wire visit (+)-MK 801 Maleate Market Top Players and Forecast till 2031. WebApr 10, 2024 · 9 brokerages have issued 1 year target prices for Bio-Techne's shares. Their TECH share price forecasts range from $88.00 to $120.00. On average, they anticipate the company's stock price to reach $104.36 in the next year. This suggests a possible upside of 42.7% from the stock's current price.
WebBIO-TECHNE DECLARES DIVIDEND. Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share …
Web1 day ago · More news releases in similar topics. Medical Equipment; Health Care & Hospitals; Biotechnology; Medical Pharmaceuticals; Trade Show News; Contact Cision. … flora and associatesWebApr 12, 2024 · MINNEAPOLIS, April 12, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and … flora anderson facebookWebFeb 28, 2024 · BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM. … A highly accurate new tool for the direct detection of HPV mRNA in FFPE tissue … Our press releases may contain forward-looking statements within the meaning … flora allen wife of richard allenWebNov 28, 2024 · press releases; ir calendar; email alerts; jan 26, 2024. bio-techne launches the mauriceflex™ system, adding cief fractionation capability to the gold standard … great road journeys of the worldWeb1 day ago · Print. Bio-Techne Corp. is expanding into the realm of diagnostics with its ExoDx Prostate cancer test and a development pipeline of comparable products — a new area … flora and bast clarifying facial treatmentWebTECH: Get the latest Bio-Techne stock price and detailed information including TECH news, historical charts and realtime prices. ... Q4 2024 Earnings Release: 08/08/2024: Earnings Report - Q1 2024 ... flora and curlWebApr 10, 2024 · The MarketWatch News Department was not involved in the creation of this content. Apr 10, 2024 (The Expresswire) -- "Friedreich Ataxia Market" information for each competitor includes (Healx, Bio ... flora anaesthesia